cannabis indica

Canabigerol (CBG)

termo de indexação original: Cannabigerol (CBG)

O que é Canabigerol (CBG)

O canabigerol, ou CBG, é um fitocanabinoide não psicoativo. Sua importância é sobretudo estrutural: sua forma ácida, o CBG-a, é o precursor a partir do qual a planta sintetiza THC-a, CBD-a e CBC-a. Por isso o CBG é chamado de molécula-mãe dos canabinoides.

Justamente por ser consumido nessa conversão, o CBG aparece em concentrações baixas na maioria das variedades maduras — em geral abaixo de 1%. Variedades selecionadas e colheitas precoces produzem teores maiores, o que tornou o composto viável para pesquisa e para produtos nos últimos anos.

Farmacologicamente o CBG tem afinidade fraca por CB1 e CB2 e interage com outros alvos, incluindo receptores alfa-2-adrenérgicos, 5-HT1A e canais TRP. Esse perfil misto é o que motiva a maior parte dos estudos que o citam.

No acervo

O acervo do Cannabis Indica reúne 162 estudos científicos que tocam o composto Canabigerol (CBG), publicados entre 1970 e 2024. Pela leitura automatizada, 117 (72%) foram classificados como favoráveis, 34 (21%) como inconclusivos e 11 (7%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é estudo laboratorial (63 estudos), seguido de metanálise (60). As condições mais associadas são Câncer, Inflamação e Dor.

Estudos indexados
162
Período coberto
1970–2024
Favoráveis
117 · 72%
Inconclusivos
34 · 21%
Desfavoráveis
11 · 7%
Termo original
Cannabigerol (CBG)

O acervo em números

Tipo de estudo

Estudo Laboratorial63
Metanálise60
Estudo em Animais28
Ensaio Clínico Duplo-Cego6
Ensaio Clínico2
Metanálise Clínica2
Ensaio Clínico Veterinário1

Direção do resultado

Favorável117
Inconclusivo34
Desfavorável11

Por década

1970s1
1990s1
2000s5
2010s40
2020s115

162 estudos

Filtrar e buscar no acervo →
  1. 2024

    Anticancer effect of minor phytocannabinoids in preclinical models of multiple myeloma

    FavorávelEstudo em AnimaisCâncer — MielomaCanabinol (CBN)Canabicromeno (CBC)+1
  2. 2024

    Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality

    InconclusivoMetanáliseDorDor — AgudaAnandamida (AEA)Tetraidrocanabinol (THC)+7
  3. 2024

    Editorial: Insights on cannabinoid translational science and medicine: the endocannabinoidome as a target for clinical practice

    FavorávelMetanáliseAnandamida (AEA)Tetraidrocanabinol (THC)+9
  4. 2024

    The inhibitory effects of cannabinoids, the active constituents of Cannabis sativa L. on human and rabbit platelet aggregation

    InconclusivoEstudo LaboratorialDistúrbios de CoagulaçãoTetraidrocanabinol (THC)Canabinol (CBN)
  5. 2023

    A Case of Panic Attacks Developing After 10 Years of Chronic Cannabis Use in a Patient With No Prior Psychiatric History

    DesfavorávelMetanáliseDorCâncerInflamaçãoTetraidrocanabinol (THC)+14
  6. 2023

    A randomized, double-blind, placebo-controlled, repeated-dose pilot study of the safety, tolerability, and preliminary effects of a cannabidiol (CBD)- and cannabigerol (CBG)-based beverage powder to support recovery from delayed onset muscle soreness (DOMS)

    FavorávelEnsaio Clínico Duplo-CegoDorDor — AgudaEndocanabinoide (não especificado)
  7. 2023

    Biotechnological Fungal Platforms for the Production of Biosynthetic Cannabinoids

    FavorávelEstudo LaboratorialDorCâncerInflamaçãoTetraidrocanabinol (THC)THC Farmacêutico+25
  8. 2023

    Cannabidiol (CBD) with 4',7-Isoflavandiol (Equol) Efficacy is Greater than CBD or Equol Treatment Alone via Human Skin Gene Expression Analysis

    FavorávelEstudo LaboratorialInflamaçãoEstresse OxidativoDoenças de Pele+3
  9. 2023

    Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance

  10. 2023

    Combining cannabis and melatonin treatment with a rehabilitation program improved symptoms in a dog with compulsive disorder: A case report

    FavorávelEnsaio Clínico VeterinárioAplicações Veterinárias
  11. 2023

    Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance

    FavorávelMetanáliseCâncerInflamaçãoAnsiedadeCanabinol (CBN)Canabicromeno (CBC)+20
  12. 2023

    Film Forming Systems for Delivery of Active Molecules into and across the Skin

    FavorávelEstudo LaboratorialDorDoenças de Pele
  13. 2023

    Phytocannabinoids: Pharmacological effects, biomedical applications, and worldwide prospection

    InconclusivoMetanálise ClínicaDorCâncerAnsiedadeTHC FarmacêuticoTHC:CBD Farmacêutico+9
  14. 2023

    The antinociceptive activity and mechanism of action of cannabigerol

  15. 2022

    A Review on the Bioactivity of Cannabinoids on Zebrafish Models: Emphasis on Neurodevelopment

    FavorávelMetanáliseDorCâncerAnsiedadeAnandamida (AEA)Tetraidrocanabinol (THC)+25
  16. 2022

    Acute Cannabigerol Administration Lowers Blood Pressure in Mice

  17. 2022

    An Examination of the Anti-Cancer Properties of Plant Cannabinoids in Preclinical Models of Mesothelioma

    FavorávelEstudo LaboratorialCâncerInflamaçãoCâncer — Tecidos Moles
  18. 2022

    Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways

    FavorávelEstudo LaboratorialCâncerCicatrizaçãoCâncer — Fígado
  19. 2022

    Cannabigerol (CBG) attenuates mechanical hypersensitivity elicited by chemotherapy-induced peripheral neuropathy

  20. 2022

    Cannabinoids-Perspectives for Individual Treatment in Selected Patients: Analysis of the Case Series

  21. 2022

    Cannabinoids: Therapeutic Use in Clinical Practice

  22. 2022

    Cannabis for Medical Use: Versatile Plant Rather Than a Single Drug

  23. 2022

    Cannabis sativa Extract Induces Apoptosis in Human Pancreatic 3D Cancer Models: Importance of Major Antioxidant Molecules Present Therein

  24. 2022

    Cannabis Use and the Endocannabinoid System: A Clinical Perspective

  25. 2022

    Cannabis vaping: existing and emerging modalities, chemistry, and pulmonary toxicology

  26. 2022

    Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review

    FavorávelMetanáliseDorCâncerInflamaçãoAnandamida (AEA)Tetraidrocanabinol (THC)+28
  27. 2022

    Cutaneous Squamous Cell Carcinoma and Lichen Simplex Chronicus Successfully Treated with Topical Cannabinoid Oil: A Case Report and Summary of Cannabinoids in Dermatology

  28. 2022

    Effects of Rare Phytocannabinoids on the Endocannabinoid System of Human Keratinocytes

    FavorávelEstudo LaboratorialDoenças de PeleAnandamida (AEA)Endocanabinoide (não especificado)+7
  29. 2022

    Effects of rich cannabidiol oil on behavioral disturbances in patients with dementia: A placebo controlled randomized clinical trial

    FavorávelEnsaio Clínico Duplo-CegoAnandamida (AEA)Tetraidrocanabinol (THC)+3
  30. 2022

    Effects of short-term environmental stresses on the onset of cannabinoid production in young immature flowers of industrial hemp (Cannabis sativa L.)

  31. 2022

    Fetal Exposure to Cannabis and Childhood Metabolic Outcomes: The Healthy Start Study

  32. 2022

    Geospatiotemporal and causal inference study of cannabis and other drugs as risk factors for female breast cancer USA 2003–2017

    DesfavorávelMetanáliseCâncerDependência — ÁlcoolCâncer — Mama
  33. 2022

    Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 1 - continuous bivariate analysis

    DesfavorávelMetanáliseCâncerCanabinol (CBN)Canabicromeno (CBC)
  34. 2022

    In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties

    FavorávelEstudo LaboratorialInflamaçãoDoenças de Pele
  35. 2022

    In vitro percutaneous absorption studies of cannabidiol using human skin: Exploring the effect of drug concentration, chemical enhancers, and essential oils

    FavorávelEstudo LaboratorialDorCâncerInflamaçãoAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+14
  36. 2022

    Industrial Hemp ( Cannabis sativa L.) Inflorescences as Novel Food: The Effect of Different Agronomical Practices on Chemical Profile

    InconclusivoEstudo LaboratorialCanabinol (CBN)Canabicromeno (CBC)+3
  37. 2022

    Inhibitory Effects of Cannabinoids on Acetylcholinesterase and Butyrylcholinesterase Enzyme Activities

    InconclusivoEstudo LaboratorialCanabinol (CBN)Canabicromeno (CBC)+3
  38. 2022

    Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapies

  39. 2022

    Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review

  40. 2022

    Medical Cannabis Activity Against Inflammation: Active Compounds and Modes of Action

    FavorávelMetanáliseInflamaçãoTetraidrocanabinol (THC)
  41. 2022

    Non-psychotropic phytocannabinoid interactions with voltage-gated sodium channels: An update on cannabidiol and cannabigerol

    FavorávelMetanáliseDorDor — CrônicaDor — Aguda
  42. 2022

    Parkinson’s Disease and Dementia with Lewy Bodies, Patients Under Treatment with Standardized Extracts Enriched in Cannabidiol and Cannabigerol: Descriptive Observations in Preparation for a Phase 2a Clinical Trial

    FavorávelMetanáliseDorAnsiedadePsicoseTetraidrocanabinol (THC)+4
  43. 2022

    Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives

  44. 2022

    Phytocannabinoid Compositions from Cannabis Act Synergistically with PARP1 Inhibitor against Ovarian Cancer Cells In Vitro and Affect the Wnt Signaling Pathway

  45. 2022

    Phytocannabinoids and Cannabis-Based Products as Alternative Pharmacotherapy in Neurodegenerative Diseases: From Hypothesis to Clinical Practice

  46. 2022

    Phytocannabinoids regulate inflammation in IL-1β-stimulated human gingival fibroblasts

  47. 2022

    Post-Harvest Operations to Generate High-Quality Medicinal Cannabis Products: A Systemic Review

    InconclusivoMetanáliseCanabinol (CBN)Canabicromeno (CBC)+2
  48. 2022

    Profiling Cannabinoid Contents and Expression Levels of Corresponding Biosynthetic Genes in Commercial Cannabis (Cannabis sativa L.) Cultivars

    InconclusivoEstudo LaboratorialTetraidrocanabinol (THC)Canabinol (CBN)+8
  49. 2022

    Regulating for Safety: Cannabidiol Dose in Food: A Review

    DesfavorávelMetanáliseCanabinol (CBN)Canabicromeno (CBC)+5
  50. 2022

    Sebaceous immunobiology - skin homeostasis, pathophysiology, coordination of innate immunity and inflammatory response and disease associations

  51. 2022

    Sex differences in medical cannabis-related adverse effects

  52. 2022

    Single and Repeated Exposure to Cannabidiol Differently Modulate BDNF Expression and Signaling in the Cortico-Striatal Brain Network

    FavorávelEstudo em AnimaisDoenças NeurodegenerativasTranstornos de Comportamento
  53. 2022

    Single dose and chronic oral administration of cannabigerol and cannabigerolic acid-rich hemp extract in fed and fasted dogs: Physiological effect and pharmacokinetic evaluation

    FavorávelEstudo em AnimaisAplicações VeterináriasÁcido Canabigerólico (CBG-a)
  54. 2022

    Synthetic Strategies for Rare Cannabinoids Derived from Cannabis sativa

    InconclusivoEstudo LaboratorialCanabicromeno (CBC)Delta-8-THC+1
  55. 2022

    The Cytotoxic Effects of Cannabidiol and Cannabigerol on Glioblastoma Stem Cells May Mostly Involve GPR55 and TRPV1 Signalling

    FavorávelEstudo LaboratorialCâncerCâncer — Cérebro
  56. 2022

    The Medicinal Natural Products of Cannabis sativa Linn.: A Review

  57. 2022

    The Origin and Biomedical Relevance of Cannabigerol

    FavorávelMetanáliseTetraidrocanabinol (THC)
  58. 2022

    The Role of Nutritional Status, Gastrointestinal Peptides, and Endocannabinoids in the Prognosis and Treatment of Children with Cancer

    InconclusivoMetanáliseDorCâncerObesidadeAnandamida (AEA)Tetraidrocanabinol (THC)+17
  59. 2022

    Will Cannabigerol Trigger Neuroregeneration after a Spinal Cord Injury? An In Vitro Answer from NSC-34 Scratch-Injured Cells Transcriptome

    FavorávelEstudo LaboratorialInflamaçãoEstresse OxidativoLesões da Medula Espinhal
  60. 2021

    A Comparative In Vitro Study of the Neuroprotective Effect Induced by Cannabidiol, Cannabigerol, and Their Respective Acid Forms: Relevance of the 5-HT 1A Receptors

    FavorávelEstudo LaboratorialEstresse OxidativoDoenças Neurodegenerativas
  61. 2021

    A geospatiotemporal and causal inference epidemiological exploration of substance and cannabinoid exposure as drivers of rising US pediatric cancer rates

    DesfavorávelMetanáliseCâncerEfeitos Adversos da CannabisDependência — Opioides+3
  62. 2021

    Anti-Bacterial Properties of Cannabigerol Toward Streptococcus mutans

    FavorávelEstudo LaboratorialInfecções BacterianasDoença Periodontal
  63. 2021

    Anti-Biofilm Activity of Cannabigerol against Streptococcus mutans

    FavorávelEstudo LaboratorialInfecções Bacterianas
  64. 2021

    Antioxidant function of phytocannabinoids: Molecular basis of their stability and cytoprotective properties under UV-irradiation

    FavorávelEstudo LaboratorialEstresse OxidativoCanabinol (CBN)Canabicromeno (CBC)
  65. 2021

    Biomarkers of Recent Cannabis Use in Blood, Oral Fluid and Breath

    FavorávelEnsaio Clínico Duplo-CegoCanabinol (CBN)Tetraidrocanabivarina (THCV)+1
  66. 2021

    Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host Innate Immune Response

  67. 2021

    Cannabigerol and cannabichromene in Cannabis sativa L.

  68. 2021

    Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma

    FavorávelEstudo LaboratorialCâncerCâncer — Cérebro
  69. 2021

    Cannabinoid exposure as a major driver of pediatric acute lymphoid Leukaemia rates across the USA: combined geospatial, multiple imputation and causal inference study

  70. 2021

    Cannabinoids modulate food preference and consumption in Drosophila melanogaster

  71. 2021

    Cannabis and Autoimmunity: Possible Mechanisms of Action

  72. 2021

    Cannabis compounds exhibit anti-inflammatory activity in vitro in COVID-19-related inflammation in lung epithelial cells and pro-inflammatory activity in macrophages

    InconclusivoEstudo LaboratorialInflamaçãoCOVID-19Tetraidrocanabivarina (THCV)
  73. 2021

    Cannabis sativa: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC

    FavorávelMetanáliseAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+17
  74. 2021

    CBG, CBD, Δ9-THC, CBN, CBGA, CBDA and Δ9-THCA as antioxidant agents and their intervention abilities in antioxidant action

    FavorávelEstudo LaboratorialEstresse OxidativoCanabinol (CBN)Ácido Canabidiólico (CBD-a)+2
  75. 2021

    Detectability of cannabinoids in the serum samples of cannabis users: Indicators of recent cannabis use? A follow-up study

    FavorávelEnsaio ClínicoCanabinol (CBN)Canabicromeno (CBC)+7
  76. 2021

    Development and Optimization of Supercritical Fluid Extraction Setup Leading to Quantification of 11 Cannabinoids Derived from Medicinal Cannabis

    InconclusivoEstudo LaboratorialTetraidrocanabinol (THC)Canabinol (CBN)+7
  77. 2021

    Differential Interactions of Selected Phytocannabinoids with Human CYP2D6 Polymorphisms

    InconclusivoEstudo LaboratorialAnandamida (AEA)Tetraidrocanabinol (THC)+3
  78. 2021

    Dose-Related Inhibition of Capsaicin Responses by Cannabinoids CBG, CBD, THC and their Combination in Cultured Sensory Neurons

    FavorávelEstudo LaboratorialDorDor — CrônicaDor — AgudaCanabicromeno (CBC)Capsaicina (CAPS)
  79. 2021

    Efficacy of combined therapy with fish oil and phytocannabinoids in murine intestinal inflammation

    FavorávelEstudo em AnimaisInflamaçãoDII — Doença Inflamatória Intestinal
  80. 2021

    Efficacy of Phytocannabinoids in Epilepsy Treatment: Novel Approaches and Recent Advances

    InconclusivoMetanáliseEpilepsiaCanabidivarina (CBDV)
  81. 2021

    Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease - A Systematic Review

  82. 2021

    Epidemiological overview of multidimensional chromosomal and genome toxicity of cannabis exposure in congenital anomalies and cancer development

    DesfavorávelMetanáliseCâncerCâncer — MamaCâncer — LeucemiaCanabicromeno (CBC)+4
  83. 2021

    Fast liquid chromatography-tandem mass spectrometry method for the simultaneous determination of phytocannabinoids in oily based preparations

    InconclusivoEstudo LaboratorialCanabinol (CBN)Ácido Canabidiólico (CBD-a)+2
  84. 2021

    Fighting the storm: could novel anti-TNFα and anti-IL-6 C. sativa cultivars tame cytokine storm in COVID-19?

    InconclusivoEstudo LaboratorialCOVID-19Canabinol (CBN)Ácido Tetraidrocanabinólico (THC-a)+1
  85. 2021

    Identification and quantification of cannabinoids in postmortem fluids and tissues by liquid chromatography-tandem mass spectrometry

    InconclusivoEstudo LaboratorialCanabinol (CBN)Tetraidrocanabivarina (THCV)
  86. 2021

    Inhibition of sodium conductance by cannabigerol contributes to a reduction of dorsal root ganglion neuron excitability

    FavorávelEstudo LaboratorialDorDor — Aguda
  87. 2021

    Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses

    FavorávelMetanáliseCanabinol (CBN)Canabicromeno (CBC)+3
  88. 2021

    Neuroprotection with the cannabigerol quinone derivative VCE-003.2 and its analogs CBGA-Q and CBGA-Q-Salt in Parkinson's disease using 6-hydroxydopamine-lesioned mice

    FavorávelEstudo em AnimaisDoença de Parkinson
  89. 2021

    Novel CBG Derivatives Can Reduce Inflammation, Pain and Obesity

    FavorávelEstudo em AnimaisDorInflamaçãoDor — Crônica+1
  90. 2021

    Orally administered cannabidiol does not produce false-positive tests for Δ9 -tetrahydrocannabinol on the Securetec DrugWipe® 5S or Dräger DrugTest® 5000

    InconclusivoEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisCanabinol (CBN)
  91. 2021

    Protective Effects of Cannabidivarin and Cannabigerol on Cells of the Blood–Brain Barrier Under Ischemic Conditions

  92. 2021

    Quantitation of Δ8-THC, Δ9-THC, Cannabidiol, and Ten Other Cannabinoids and Metabolites in Oral Fluid by HPLC-MS/MS

    InconclusivoEstudo LaboratorialCanabinol (CBN)Canabicromeno (CBC)+3
  93. 2021

    Screening and confirmation methods for the qualitative identification of nine phytocannabinoids in urine by LC-MS/MS

    InconclusivoEstudo LaboratorialCanabinoide Sintético (não especificado)THC Farmacêutico+2
  94. 2021

    Specific Compositions of Cannabis sativa Compounds Have Cytotoxic Activity and Inhibit Motility and Colony Formation of Human Glioblastoma Cells In Vitro

  95. 2021

    Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms

    FavorávelMetanáliseDorAnsiedadeDor — Crônica+2
  96. 2021

    The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination

    FavorávelEstudo em AnimaisInflamação
  97. 2021

    The antimicrobial effect behind Cannabis sativa

    FavorávelMetanáliseInfecções BacterianasAnandamida (AEA)Canabinol (CBN)+5
  98. 2021

    The Cannabis Constituent Cannabigerol Does Not Disrupt Fear Memory Processes or Stress-Induced Anxiety in Mice

    InconclusivoEstudo em AnimaisAnsiedadeDisfunção CognitivaTEPT
  99. 2021

    The Current and Potential Application of Medicinal Cannabis Products in Dentistry

  100. 2021

    The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of In Vivo Studies

    FavorávelMetanáliseDorInflamaçãoDor — Neuropatia Periférica
  101. 2021

    The Effects of Cannabis sativa L. Extract on Oxidative Stress Markers In Vivo

    FavorávelEstudo em AnimaisInflamaçãoEstresse OxidativoÁcido Canabidiólico (CBD-a)
  102. 2020

    A systematic review of minor phytocannabinoids with promising neuroprotective potential

  103. 2020

    Attenuation of Oxidative Stress by Cannabinoids and Cannabis Extracts in Differentiated Neuronal Cells

  104. 2020

    Cannabinoid Combination Induces Cytoplasmic Vacuolation in MCF-7 Breast Cancer Cells

    FavorávelEstudo LaboratorialCâncerCâncer — MamaTetraidrocanabinol (THC)Canabinol (CBN)
  105. 2020

    Cannabinoids and Cannabinoid Receptors: The Story so Far

    InconclusivoMetanáliseAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+5
  106. 2020

    Comparison of Efficacy of Cannabinoids versus Commercial Oral Care Products in Reducing Bacterial Content from Dental Plaque: A Preliminary Observation

    FavorávelEstudo LaboratorialCáriesCanabinol (CBN)Canabicromeno (CBC)+1
  107. 2020

    In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa

    InconclusivoEstudo LaboratorialCanabicromeno (CBC)Ácido Canabidiólico (CBD-a)+3
  108. 2020

    Ingestion of a THC-Rich Cannabis Oil in People with Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

    FavorávelEnsaio Clínico Duplo-CegoDorDepressãoInsônia e Distúrbios do SonoCanabinol (CBN)Canabicromeno (CBC)+3
  109. 2020

    It Is Our Turn to Get Cannabis High: Put Cannabinoids in Food and Health Baskets

    FavorávelMetanáliseTHC FarmacêuticoTHC:CBD Farmacêutico+4
  110. 2020

    Phytocannabinoid-dependent mTORC1 regulation is dependent upon inositol polyphosphate multikinase activity

    FavorávelEstudo LaboratorialEsclerose MúltiplaÁcido Canabidiólico (CBD-a)Canabidivarina (CBDV)
  111. 2020

    Phytocannabinoids promote viability and functional adipogenesis of bone marrow-derived mesenchymal stem cells through different molecular targets

  112. 2020

    Synergistic Cytotoxic Activity of Cannabinoids From cannabis sativa Against Cutaneous T-cell Lymphoma (CTCL) in-vitro and ex-vivo

    FavorávelEstudo LaboratorialCâncerCâncer — LinfomaCanabicromeno (CBC)
  113. 2020

    The Influence of Hemp Extract in Combination with Ginger on the Metabolic Activity of Metastatic Cells and Microorganisms

  114. 2020

    The pharmacological case for cannabigerol (CBG)

  115. 2020

    Uncovering the Hidden Antibiotic Potential of Cannabis

    FavorávelEstudo em AnimaisInfecção por Estafilococos
  116. 2019

    A Review on Studies of Marijuana for Alzheimer's Disease - Focusing on CBD, THC

    FavorávelMetanáliseCâncerInflamaçãoDisfunção CognitivaCanabinol (CBN)+5
  117. 2019

    Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System

  118. 2019

    Chemotherapy‐induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol

  119. 2019

    Diverse TRPV1 responses to cannabinoids

    InconclusivoEstudo LaboratorialDorDor — CrônicaDor — Neuropatia PeriféricaCanabinol (CBN)
  120. 2019

    Future Aspects for Cannabinoids in Breast Cancer Therapy

  121. 2019

    Identification and characterization of phytocannabinoids as novel dual PPARα/γ agonists by a computational and in vitro experimental approach

    InconclusivoEstudo LaboratorialÁcido Canabidiólico (CBD-a)Ácido Canabigerólico (CBG-a)
  122. 2019

    Simultaneous Quantification of 13 Cannabinoids and Metabolites in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry in Adult Epilepsy Patients

    InconclusivoMetanáliseEpilepsiaTetraidrocanabinol (THC)Canabinol (CBN)+5
  123. 2019

    The Endocannabinoid System of Animals

  124. 2018

    Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis.

  125. 2018

    Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1–CB2 Heteroreceptor Complexes

    InconclusivoEstudo Laboratorial
  126. 2018

    Cannabinoids, the Heart of the Matter.

  127. 2018

    Identification of Synergistic Interaction Between Cannabis-Derived Compounds for Cytotoxic Activity in Colorectal Cancer Cell Lines and Colon Polyps That Induces Apoptosis-Related Cell Death and Distinct Gene Expression

  128. 2018

    In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid

    FavorávelEstudo LaboratorialInflamaçãoEstresse OxidativoDoenças Neurodegenerativas+3
  129. 2018

    Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs.

    FavorávelEstudo em AnimaisAplicações VeterináriasTetraidrocanabinol (THC)Canabicromeno (CBC)+1
  130. 2018

    The Use of Cannabinoids in Colitis: A Systematic Review and Meta-Analysis.

  131. 2017

    A Cannabigerol-rich Cannabis Sativa Extract, Devoid Of Delta 9-tetrahydrocannabinol, Elicits Hyperphagia In Rats

    FavorávelEstudo em AnimaisAnorexia (perda de apetite)CaquexiaAnorexia Nervosa
  132. 2017

    Anticancer Effects Of Phytocannabinoids Used With Chemotherapy In Leukaemia Cells Can Be Improved By Altering The Sequence Of Their Administration

    FavorávelEstudo LaboratorialCâncerCâncer — LeucemiaTetraidrocanabinol (THC)
  133. 2017

    Cannabinoid CB2 Receptors are Involved in the Protection of RAW264.7 Macrophages Against the Oxidative Stress: An in Vitro Study

  134. 2017

    Molecular Targets of the Phytocannabinoids-A Complex Picture

    InconclusivoMetanáliseTetraidrocanabinol (THC)Canabinol (CBN)+3
  135. 2017

    Recent advances in the endocrinology of the sebaceous gland

  136. 2017

    Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges.

  137. 2017

    Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity.

  138. 2016

    Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats

    FavorávelEstudo em AnimaisAnorexia (perda de apetite)CaquexiaAnorexia Nervosa
  139. 2016

    Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake

    InconclusivoEnsaio Clínico Duplo-CegoCanabinol (CBN)Tetraidrocanabivarina (THCV)
  140. 2015

    Effect of Non-psychotropic Plant-derived Cannabinoids on Bladder Contractility: Focus on Cannabigerol

    FavorávelEstudo LaboratorialCistiteCanabicromeno (CBC)
  141. 2015

    Neuroprotective Properties of Cannabigerol in Huntington’s Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice

    FavorávelEstudo em AnimaisDoença de Huntington
  142. 2015

    The Effect of Phytocannabinoids on Airway Hyper-Responsiveness, Airway Inflammation, and Cough.

    FavorávelEstudo em AnimaisTosseTetraidrocanabinol (THC)Canabinoides Sintéticos AM-x+4
  143. 2014

    A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis.

  144. 2014

    Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid.

    FavorávelEstudo em AnimaisCâncerCâncer — Cólon
  145. 2014

    TRP Channel Cannabinoid Receptors In Skin Sensation, Homeostasis, And Inflammation

    FavorávelMetanáliseAcneSeborreiaCanabicromeno (CBC)
  146. 2014

    Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se.

    FavorávelEstudo em AnimaisEpilepsiaEpilepsia — Síndrome de Dravet
  147. 2013

    Analysis of cannabis seizures in NSW, Australia: cannabis potency and cannabinoid profile

  148. 2013

    Cannabinoid Hyperemesis Syndrome

  149. 2013

    Non-THC Cannabinoids Inhibit Prostate Carcinoma Growth In Vitro And In Vivo: Pro-apoptotic Effects And Underlying Mechanisms

    FavorávelEstudo em AnimaisCâncerCâncer — PróstataCanabinol (CBN)Canabicromeno (CBC)+4
  150. 2012

    Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation

  151. 2012

    Modulation of l-α-Lysophosphatidylinositol/GPR55 Mitogen-activated Protein Kinase (MAPK) Signaling by Cannabinoids

    InconclusivoEstudo LaboratorialDorCâncerCanabinoides Sintéticos AM-xCanabinoides Sintéticos WIN-x+10
  152. 2012

    Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour.

    FavorávelEstudo em AnimaisAnsiedadeTOCTetraidrocanabivarina (THCV)
  153. 2011

    Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.

  154. 2011

    Evaluation Of The Cyclooxygenase Inhibiting Effects Of Six Major Cannabinoids Isolated From Cannabis Sativa

  155. 2010

    Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.

    FavorávelEstudo em AnimaisDepressãoTetraidrocanabinol (THC)Canabinol (CBN)+1
  156. 2008

    Antibacterial Cannabinoids from Cannabis sativa: A Structure−Activity Study.

    FavorávelEstudo LaboratorialInfecção por EstafilococosTetraidrocanabinol (THC)Canabinol (CBN)+1
  157. 2008

    The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin

    InconclusivoMetanáliseTetraidrocanabivarina (THCV)Delta-8-THC
  158. 2006

    Anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma

  159. 2006

    Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis.

  160. 2005

    Therapeutic opportunities through modulation of the endocannabinoid system

  161. 1998

    Boron trifluoride etherate on silica-A modified Lewis acid reagent (VII). Antitumor activity of cannabigerol against human oral epitheloid carcinoma cells

    FavorávelEstudo LaboratorialCâncerCâncer — Boca
  162. 1970

    Chemical basis of hashish activity

Continue por aqui

Perguntas frequentes

Quantos estudos sobre canabigerol (cbg) estão indexados no acervo?
São 162 estudos, publicados entre 1970 e 2024. O acervo inteiro tem 7.640 registros.
Que tipos de estudo predominam?
Estudo Laboratorial: 63 · Metanálise: 60 · Estudo em Animais: 28 · Ensaio Clínico Duplo-Cego: 6 · Ensaio Clínico: 2 · Metanálise Clínica: 2 · Ensaio Clínico Veterinário: 1. A classificação segue o desenho declarado na fonte.
O que significa a classificação de resultado?
É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 117 favoráveis, 34 inconclusivos e 11 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. Canabigerol (CBG) — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/canabinoide/canabigerol-cbg/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). Canabigerol (CBG) — estudos científicos sobre cannabis. https://cannabisindica.com.br/canabinoide/canabigerol-cbg/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.